Indefinite Delivery Contract SPE2DB25D9308

Award Date 9/10/24
Last Date to Order 11/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award indefinite delivery contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $499,999,999, runs through November 30, 2026 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military...
The federal contract IDV award, valued at up to $499,999,999, is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, and it runs through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999.00, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, has a ceiling value of $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to fulfill...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC, valued up to $499,999,999, is part of the SPE2DB program and runs through November 30, 2026. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded on June 6, 2024, provides the DLA with a vehicle to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to meet the recurring medical supply needs of military health facilities worldwide. The contract, under the SPE2DB...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, aims to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The IDC allows the DLA to issue firm...
The federal contract IDV award, valued at up to $499,999,999, is a single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is with the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a...
The key features of this federal contract IDV award are as follows: The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The IDC, valued at up to $499,999,999, runs through November 30, 2026 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of...
  • SPE2DB25D9308
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide under the SPE2DB program.

Through this IDC, DMS Pharmaceutical Group provides a diverse array of pharmaceutical items to the DLA, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The supplied products span common medications like antibiotics, pain relievers, and cardiovascular drugs, as well as specialized pharmaceuticals such as flumazenil injections, prednisone tablets, oncology drugs, and specialty medications. This IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare facilities, solidifying the company's position as a critical supplier in the federal pharmaceutical supply chain.

Generated 1/1/25, 9:04 AM